CEA INDUSTRIES INC (CEAD)

US86887P2002 - Common Stock

0.711  0 (0%)

Premarket: 0.8 +0.09 (+12.52%)

Fundamental Rating

2

Taking everything into account, CEAD scores 2 out of 10 in our fundamental rating. CEAD was compared to 43 industry peers in the Building Products industry. While CEAD has a great health rating, there are worries on its profitability. CEAD does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

CEAD had negative earnings in the past year.
CEAD had a negative operating cash flow in the past year.
CEAD had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CEAD reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -21.10%, CEAD is not doing good in the industry: 90.70% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -23.71%, CEAD is doing worse than 83.72% of the companies in the same industry.
Industry RankSector Rank
ROA -21.1%
ROE -23.71%
ROIC N/A
ROA(3y)-39.81%
ROA(5y)-37.82%
ROE(3y)-336.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 7.82%, CEAD is doing worse than 95.35% of the companies in the same industry.
In the last couple of years the Gross Margin of CEAD has declined.
CEAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.48%
GM growth 5Y-21.05%

7

2. Health

2.1 Basic Checks

CEAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CEAD has more shares outstanding
Compared to 5 years ago, CEAD has more shares outstanding
There is no outstanding debt for CEAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CEAD has an Altman-Z score of -0.61. This is a bad value and indicates that CEAD is not financially healthy and even has some risk of bankruptcy.
CEAD's Altman-Z score of -0.61 is on the low side compared to the rest of the industry. CEAD is outperformed by 90.70% of its industry peers.
There is no outstanding debt for CEAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.61
ROIC/WACCN/A
WACC11.61%

2.3 Liquidity

A Current Ratio of 10.68 indicates that CEAD has no problem at all paying its short term obligations.
CEAD has a Current ratio of 10.68. This is amongst the best in the industry. CEAD outperforms 97.67% of its industry peers.
CEAD has a Quick Ratio of 10.44. This indicates that CEAD is financially healthy and has no problem in meeting its short term obligations.
CEAD has a Quick ratio of 10.44. This is amongst the best in the industry. CEAD outperforms 97.67% of its industry peers.
Industry RankSector Rank
Current Ratio 10.68
Quick Ratio 10.44

0

3. Growth

3.1 Past

CEAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.16%, which is quite impressive.
Looking at the last year, CEAD shows a very negative growth in Revenue. The Revenue has decreased by -38.73% in the last year.
Measured over the past years, CEAD shows a decrease in Revenue. The Revenue has been decreasing by -6.32% on average per year.
EPS 1Y (TTM)61.16%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q23.58%
Revenue 1Y (TTM)-38.73%
Revenue growth 3Y-6.7%
Revenue growth 5Y-6.32%
Revenue growth Q2Q-82.8%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CEAD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CEAD!.
Industry RankSector Rank
Dividend Yield N/A

CEA INDUSTRIES INC

NASDAQ:CEAD (5/16/2024, 7:00:00 PM)

Premarket: 0.8 +0.09 (+12.52%)

0.711

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.84M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.1%
ROE -23.71%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 7.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.68
Quick Ratio 10.44
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.16%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-38.73%
Revenue growth 3Y-6.7%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y